Apolipoprotein E (apoE) is widely distributed among plasma lipoproteins and mainly functions as a ligand in the receptor-mediated catabolism of lipoproteins which contain apoE (especially remnants) (1, 2) . Most apoE in plasma is associated with very low density lipoprotein (VLDL) and high density lipoprotein (HDL) fractions, and is transferable between them (3, 4). In HDL fractions containing a large amount of apoE, it is usually associated with HDLc or HDL1 which are known to be increased by high cholesterol diets (5) and in patients with homozygous familial hypercholesterolemia (6) and hyperalphalipoproteinemia with cholesteryl ester transfer protein (CETP) deficiency (7). It is reported that increased apoE-rich HDL is characteristic of hyper HDL-cholesterolemia with CETP-deficiency (7). However, little is known about the nature and clinical significance of lipoproteins which contain apoE in the HDL fraction (HDL-fr). In this study, we determined apoE in HDL-fr by the immunofixation method after agarose gel electrophoresis and turbidimetric immunoassay (TIA) after precipitation with phosphotungstic acid/MgCl2 in normolipidemic control subjects, and patients with type IV hyperlipemia and hyper HDL-cholesterolemia.
Subjects and Methods

Subjects
Serum samples were obtained from normolipidemic control subjects, and patients with type IV hyperlipemia (without any complications) and hyper HDL-cholesterolemia (including pregnant women and healthy men) after an overnight fast. Informed consent was obtained from all the subjects (aged 20 to 60 yrs) prior to enrollment in the study. Serum HDL-cholesterol (HDL-ch) levels in subjects with hyper HDL-cholesterolemia were all higher than 70 mg/dl, which is the upper limit of the reference range in our laboratory. Characteristics of the subjects are shown in Table 1 . In these subjects, mean (and range) daily intake of total fat, calories from fat , and cholesterol which were estimated from their own reports on diet for the week before enrollment in the study were 66.8 g (32.2-109.5 g), 25.5% (17.1-35.1%), and 320.7 mg (195.2 -488 mg), respectively. The polyunsaturated/ saturated fat ratio was 0.58 (0.26-1.12). All alcohol users consumed less than 40 g ethanol per day, and smokers consumed fewer than 15 cigarettes per day. No subject was taking any medication.
No significant differences were found in mean age, mean body mass index (BMI) , proportion of alcohol users or smokers between control and patients with hyper HDL-cholesterolemia or type IV hyperlipemia except for a difference in the proportion of alcohol users between the male control and male subjects with hyper HDL-cholesterolemia.
Assays
Samples were used for routine laboratory tests, including assays of total cholesterol (Tch), triglycerides (TG) , HDL-ch, and apolipoproteins A-I (apoA-I) , B (apoB) and E. and the samples after precipitation were applied to electrophoresis on a 2-15% linear gradient polyacrylamide gel and transferred to polyvinylidene difluoride (PVDF) membrane for immunoblotting with anti-apoE anti-serum . ApoE phenotype was ascertained in the subjects with hyper HDL-cholesterolemia by isoelectric focusing with 5% polyacrylamide gel containing 2% Ampholine (pH 3 .5-10) and 8 M urea. The serum sample was incubated with neuraminidase solution, delipidated with ethanol and diethyl ether, and solubilized in 10 mM Tris-HCI containing 8 M urea and 10 mM dithiothreitol (pH 8.6). After electrophoresis, the separated sample was transferred to a PVDF membrane for immunoblotting with anti-apoE 
Results
As shown in Fig. 1 In four control subjects (two men and two women), levels of Tch and TG in pHDL-fr were compared with those in HDL-fr separated by ultracentrifugation. Total cholesterol and TG levels in pHDL-fr were slightly lower than those in HDL-fr separated by ultracentrifugation. Differences in Tch levels between these fractions ranged from 0.2 to 8.6 mg/dl, and those in TG levels ranged from 2.3 to 10.8 mg/dl. Also, immunofixation of apoE in the serum, from which apoA-I and apoB were removed with (A) (B) (c) Fig. 3 . Immunoblotting of apolipoprotein E after gradient gel electrophoresis of the peak fraction of apolipoprotein E in fractionated HDL on an agarose chromatogram (the fraction number 79 in Fig. 2) . The sample was used as native and after precipitation.
W ; whole sample, S ; supernatant, P ; precipitate was suggested ( Fig. 1 and Table 1 ). This possible correlation in apoE content implies the existence of a close interaction between these particles. It has been reported that post-heparin lipolysis causes the transfer of apoE from TG-rich lipoproteins to HDL (14) . Another report describes the transfer of apolipoprotein C-II from VLDL to HDL (especially to HDL2) with a positive correlation between LPL activity and plasma HDL-ch (especially HDL2-ch but not HDL3-ch) in familial hyperalphalipoproteinemic and normal subjects (15). The observations from the present clinical study also indicate that distribution of apoE in pHDL-fr could be affected by the negative correlation between TG and HDL-ch levels in blood, though apoE in pHDL-fr varied widely in contrast with HDL-ch levels in normo-and hyper HDL-cholesterolemic subjects.
However, apoE in pHDL-fr showed a significant positive correlation with HDL2-ch, but not with HDL3-ch. The inverse correlation between TG and HDL-ch, and apoE distribution in HDL is considered to be involved in LPL-mediated hydrolysis of TG-rich lipoproteins followed by transfer of degraded particles to HDL2.
ApoE phenotype is also known to affect the apoE distribution among lipoproteins.
There is a report that apoE3 is likely to be distributed in HDL, whereas apoE4 is not (16). Differential regulation of hepatic lipase by apoE phenotype may play a role in the apoE distribution (17). However, in our subjects with hyper HDL-cholesterolemia which showed widely varied levels of apoE in pHDL-fr, apoE phenotype was not significantly related with apoE in pHDL-fr, though the effect of infrequent apoE phenotype groups such as E4/4 or E2/2 is still unknown. Thus, it is suggested that the variation of apoE in pHDL-fr mainly depends on the variation of HDL2. Also, it may be suggested that apoE in pHDL-fr and precipitatable cr-apoE belong to low and high molecular HDL2, respectively, and that there is a correlation in apoE content between these particles.
In conclusion, determination of apoE in pHDL-fr may be a simple clinical method to evaluate HDL2 metabolism.
